This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by McLennan, D. N Articles by Brien, J.-a. E Search for Related Content PubMed Articles by McLennan, D. N Articles by Brien, J.-a. E Social Bookmarking                   What's this?

Beneficial clinical outcomes resulting from pharmacist interventions

Department of Pharmacy Practice, Victorian College of Pharmacy, Monash University, Victoria, Australia

Michael J Dooley, BPharm

Department of Pharmacy Practice, Victorian College of Pharmacy, Monash University, Victoria, Australia, Pharmacy Department, Peter MacCallum Cancer Institute, East Melbourne, Victoria, Australia

Jo-anne E Brien, BPharm, BS(Pharm), PharmD

Department of Pharmacy Practice, Victorian College of Pharmacy, Monash University, Victoria, Australia

Objective. To assess the contribution pharmacists make to patient care by determining the clinical outcomes associated with pharmacist interventions.

Methods. A 2-month prospective intervention study was conducted at Peter MacCallum Cancer Institute, a tertiary referral center. During the study, clinical pharmacists documented intervention episodes, patient demographical details, and the drug(s) involved. Clinical outcomes resulting from pharmacist-initiated changes to drug therapy and patient management were assessed by an independent pharmacist according to defined criteria. Outcomes were determined through review of patient medical progress notes and discussion with members of the health care team.

Results. A total of 674 interventions were documented during the data collection period. Outcomes could be assessed for 10% of the interventions reported, and 90% of these interventions resulted in documented clinical benefit. The drug classes most frequently associated with pharmacist interventions were antiemetics, antimicrobials, and analgesics.

Conclusion. This prospective study demonstrated a high rate of beneficial outcomes achieved by pharmacist interventions.

Key Words: Clinical outcomes • interventions

Journal of Oncology Pharmacy Practice, Vol. 5, No. 4, 184-189 (1999)
DOI: 10.1177/107815529900500404


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?